Healthcare & Life Sciences
Semprus Biosciences
United States
series-a
series-a
Stage
1
Investors
About
Semprus Biosciences developed surface-modifying polymer technologies called Endexo to reduce thrombosis and biofilm formation on blood-contacting medical devices, improving hemocompatibility and reducing infection and occlusion risks.
Explore Semprus Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.